Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132192) titled 'Establishment and Clinical Value of a Novel Diagnostic Approach for Benign and Malignant Breast Nodules Based on Circulating Tumour Cells' on Sept. 10.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Southern Medical University Southern Hospital
Condition:
Breast nodule
Intervention:
Gold Standard:Pathological findings indicate that the breast nodule is malignant
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2024-11-04
Target Sample Size: Target condition:350;Difficult condition:300
Countries of Recruitment:
China
To know more, visit ...